GE Healthcare stock tumbles as revenue falls short of expectations
GE HealthCare’s Stock Is Dropping After Earnings Beat. Here’s Why. https://t.co/HOv0A9vlmA
🔵 GE HEALTHCARE CUTS 2024 ORGANIC SALES GROWTH FORECAST, SHARES FALL Full Story → https://t.co/wUVBVF8KEG GE Healthcare On Wednesday cut its annual organic revenue growth forecast to a range of 1% to 2% from about 4%, as it expects a slowdown in China sales. https://t.co/4DG6prUmLD
GE HealthCare reported its second quarter 2024 financial results, revealing a significant revenue miss that has led to a decline in its stock price. The company announced a revised annual organic revenue growth forecast, lowering it to a range of 1% to 2%, down from approximately 4%. This adjustment is attributed to anticipated slowdowns in sales, particularly in China. Following these announcements, GE HealthCare's stock experienced a notable drop, reflecting investor concerns over the company's financial performance and outlook.